Rythmol Articles
Reliant gets US rights to Rythmol
8 December 2003
BASF sells pharma business to Abbott Labs for $6.9 billion in cash
15 December 2000
BASF excited about prospects for D2E7, as rumor mill talks of pharma
15 November 2000
Wyeth's Cordarone "treatment of choice"
6 April 2000
FDA backs Pfizer's dofetilide, launch slated for early 2000
11 October 1999
Defibrillators Outperform Drugs After Cardiac Arrest
20 April 1998
Dutch Government Reimbursement Blacklist Rises To 35
9 December 1996
KNOLL'S RYTHMOL BACKED BY FDA PANEL
4 April 1994
KNOLL AHEAD IN 1992 BUT 1st QTR FALLS
3 May 1993
SOTALOL BEST, SAYS ARRHYTHMIA STUDY
27 April 1992
STRONG EXPANSION AT KNOLL IN 1991
13 April 1992
CAST EFFECTS ON ANTI-ARRHYTHMICS
20 January 1992
Showing 1-12 of 12 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
